It is worth noting that the in vivo experiments demonstrated the efficacy of the proposed approach as such (IL MIX), since the administration of free MIX, IL ICOS-Fc, and IL MIX without ICOS-Fc failed to provide substantial therapeutic effects in terms of tumor growth, angiogenesis inhibition, and immunomodulation. The gene discussed is ICOS; the disease is neoplasm.